Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
Abstract Background Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. This study aims to assess the concentrations of LCN2 and vascular endothelial growth factor (VEGF) expressed in the vitreous humors of patients with proliferative diabet...
Main Authors: | Hui Wang, Hui Lou, Yongrong Li, Fengtao Ji, Wei Chen, Qianyi Lu, Guoxu Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-020-01462-5 |
Similar Items
-
Vitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular statusVitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular status
by: Vira S. Ponomarchuk, et al.
Published: (2021-08-01) -
Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01) -
Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
by: Dean F. Loporchio, et al.
Published: (2021-04-01) -
Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients
by: Jun-Hui Du, et al.
Published: (2014-12-01) -
Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab
by: Jiu-Ke Li, et al.
Published: (2015-12-01)